LEADER 01852nam  2200469   450 
001 9910717390603321
005 20221122055222.0
035   $a(CKB)3710000001157572
035   $a(NjHacI)993710000001157572
035   $a(OCoLC)978488921
035   $a(EXLCZ)993710000001157572
100   $a20221103d2015      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aInterventions to improve pharmacological adherence among adults with psychotic spectrum disorders, bipolar disorder, and posttraumatic stress disorder /$fKarli Kondo [and nine others]
210  1$aWashington (DC) :$cDepartment of Veterans Affairs,$d[2015]
210  4$dİ2015
215   $a1 online resource (iv, 131 pages) $cillustrations
225 1 $aEvidence-Based Synthesis Program
300   $a"November 2015."
320   $aIncludes bibliographical references.
410  0$aEvidence-based synthesis program (Series)
606   $aBipolar disorder
606   $aHallucinogenic drugs
606   $aPost-traumatic stress disorder
615  0$aBipolar disorder.
615  0$aHallucinogenic drugs.
615  0$aPost-traumatic stress disorder.
676   $a616.895
700   $aKondo$b Karli$01353458
712 02$aPortland VA Medical Center.$bEvidence-based Synthesis Program Center.
712 02$aQuality Enhancement Research Initiative (U.S.)
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910717390603321
996   $aInterventions to improve pharmacological adherence among adults with psychotic spectrum disorders, bipolar disorder, and posttraumatic stress disorder$93307474
997   $aUNINA